TransMedics Group, Inc.
TMDX
$89.36
$0.951.08%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 9.21% | 8.19% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 9.21% | 8.19% | |||
| Cost of Revenue | 5.47% | 8.05% | |||
| Gross Profit | 11.90% | 8.29% | |||
| SG&A Expenses | -8.18% | 22.44% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 3.47% | 15.16% | |||
| Operating Income | 78.51% | -37.49% | |||
| Income Before Tax | 128.70% | -60.78% | |||
| Income Tax Expenses | 303.68% | 101.40% | |||
| Earnings from Continuing Operations | 100.71% | -93.06% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 100.71% | -93.06% | |||
| EBIT | 78.51% | -37.49% | |||
| EBITDA | 35.64% | -13.38% | |||
| EPS Basic | 99.62% | -93.09% | |||
| Normalized Basic EPS | 127.43% | -60.97% | |||
| EPS Diluted | 102.85% | -92.24% | |||
| Normalized Diluted EPS | 103.34% | -55.66% | |||
| Average Basic Shares Outstanding | 0.57% | 0.48% | |||
| Average Diluted Shares Outstanding | 12.47% | -11.57% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||